Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR) [Phase 3]
Phase 3 trial of Dymista nasal spray in children aged 4-11 with seasonal allergic rhinitis has completed and results have been posted.
-
FDA approval · 2015-06-18FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Nasacort Allergy 24HR (triamcinolone acetonide) from Chattem, Inc.
-
FDA approval · 2015-05-22FDA Approved: MONTELUKAST SODIUM — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original generic application for montelukast sodium, enabling marketing of a generic montelukast pr…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Grass Pollen Subcutaneous Immunotherapy in Elderly Patients [Phase 4]
Phase 4 trial completed evaluating grass pollen subcutaneous immunotherapy in elderly patients with grass pollen allergy. The study focused …
-
FDA approval · 2015-05-04FDA Approved: MONTELUKAST — Supplemental Application (Sandoz Inc)
FDA approved a Supplemental Application for montelukast submitted by Sandoz Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-04-22Clinical Trial Update: Lactobacillus Acidophilus L92 on Markers of Allergic Inflammation by Nasal Provocation With Grass Pollen [Phase 3]
A Phase 3 trial evaluating Lactobacillus acidophilus L92 for markers of allergic inflammation in response to grass pollen for hay fever was …
-
FDA approval · 2015-04-16FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Allergy (loratadine) from Bayer HealthCare LLC.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber [Phase 2]
A Phase 2 study comparing GSK256066 to placebo in patients with seasonal allergic rhinitis/allergic rhinitis has completed, based on a polle…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma [Phase 2]
Circassia Limited announced the completion of its Grass-SPIRE Phase 2 trial in subjects with seasonal allergic rhinitis and asthma. The stud…
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber [Phase 2]
A Phase 2 trial evaluating the efficacy of Ragweed-SPIRE for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies [Phase 3]
Phase 3 clinical trial in children aged 6-11 comparing an investigational nasal aerosol to placebo for seasonal allergic rhinitis; results h…
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)
This clinical trial update describes observational usage of Loratadine (Claritin) in pediatric patients using tablet, RediTabs, and dry syru…
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma [Phase 2]
A Phase 2 safety study of Ragweed-SPIRE in subjects with ragweed allergies and asthma has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Efficacy Park Study Assessing Rhinix™ Nasal Filters for Hay Fever [NA]
A completed clinical trial evaluated the efficacy of Rhinix nasal filters for seasonal allergic rhinitis (hay fever).
-
FDA label_change · 2014-11-26FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a labeling supplemental application for Singulair (montelukast) submitted by Organon LLC.
-
FDA approval · 2014-11-19FDA Approved: FEXOFENADINE HYDROCHLORIDE — Original Application (7-eleven)
FDA approved a generic version of fexofenadine hydrochloride (ANDA 202039) for allergic rhinitis and chronic urticaria, with 7-eleven as the…
-
FDA approval · 2014-11-18FDA Approved: CHILDREN ALLERGY — Original Application (Walgreens)
FDA approved Walgreens' original application for a pediatric allergy product containing fexofenadine hydrochloride (Children Allergy).
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Compliance and Usability Study Evaluating RHINIX™ Nasal Filters [NA]
A completed usability and compliance study evaluating RHINIX nasal filters for seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis [Phase 2]
A Phase 2 trial evaluating the bioequivalence of Apotex's azelastine hydrochloride and fluticasone propionate nasal spray to Dymista for sea…
-
FDA approval · 2014-10-29FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) from Viatris Specialty LLC, under …
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis [Phase 3]
A Phase 3 trial comparing the bioequivalence of Apotex's ciclesonide nasal spray to Omnaris nasal spray in seasonal allergic rhinitis has co…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Vitamin D Plus Fluticasone Propionate [Phase 4]
Phase 4 clinical trial of vitamin D in combination with fluticasone propionate for seasonal allergic rhinitis has completed and results have…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™ [Phase 3]
A Phase 3 trial is evaluating whether a nasal spray containing azelastine hydrochloride and fluticasone propionate (137/50 mcg) is clinicall…
-
FDA approval · 2014-09-11FDA Approved: MONTELUKAST — Original Application (BluePoint Laboratories)
FDA approved Montelukast from BluePoint Laboratories under an Original Application (ANDA), granting generic montelukast access for approved …
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis [Phase 4]
Phase 4 trial comparing Fluticasone propionate nasal spray to cetirizine for seasonal allergic rhinitis, with results posted after completio…